Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-001156

Options or other derivatives

  • CFO, Treas. & Hd Corp Strategy acquired 220,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Leaman John Harold · CFO, Treas. & Hd Corp Strategy

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-11-17 Grant or award : show line 1 in the form Stock Option (right to buy) +220,000 $10.23 2027-11-16 220,000 220,000 D
Loading xslF345X03/doc4_5081.xml…